Disclosures to Attendees

Disclosure to Attendees and Learners.

Planners: The following planners have indicated (a) relevant financial relationship(s)
with an ACCME-defined ineligible company, also known as a commercial interest:
Doug Johnson
Speaker: Pfizer, Eli Lilly, Amgen, Sanofi, Regeneron, Galderma, Incyte, AbbVie,
UCB
All relevant financial relationships have been mitigated. All others in control of content
have indicated no relevant financial relationship with an ACCME-defined commercial
interest. All clinical content presented will be evidence-based and unbiased.


Faculty: The following faculty have indicated (a) relevant financial relationship(s) with an
ACCME-defined ineligible company, also known as a commercial interest:
Doug Johnson
Speaker: Pfizer, Eli Lilly, Amgen, Sanofi, Regeneron, Galderma, Incyte, AbbVie,
UCB

Marius Rademaker
Researcher: AbbVie, Galderma, Boehringer Ingelheim
Speaker: Douglas Pharmaceuticals, Pelpharma
Advisory Board: Sun Pharma, L’Oreal

Wayne Fujita
Speaker: Amgen, AbbVie, Sun Pharma
Consultant: BMS, Castle Bioscience
Speaker and Consultant: Pfizer, Galderma

All relevant financial relationships have been mitigated. All others in control of content
have indicated no relevant financial relationship with an ACCME-defined commercial
interest. All clinical content presented will be evidence-based and unbiased.